Cetuximab in combination with chemoradiotherapy prior to surgery in patients with resectable, locally advanced esophageal carcinoma: A prospective, multicenter phase lb-ll trial of the Swiss Group for Clinical Cancer Research (SAKK 75/06)
Thomas Ruhstaller(University Hospital Bonn), Viviane Hess(University Hospital of Bern), Daniel Rauch(Washington University in St. Louis), Miklos Pless(Ontario Institute for Cancer Research), Roger von Moos(Kantonsspital Graubünden), Peter M. Schneider(Max Planck Institute for Astronomy), Michael Montemurro(University Hospital of Lausanne), Jan C. Schuller(Swiss Group For Clinical Cancer Research), Peter Moosmann(University of St.Gallen), Helmut Kranzbühler(Swiss Group For Clinical Cancer Research)
Cited by 10
Related Papers
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751